Abstract
This chapter discusses molecular determinants in pulmonary hypertension. Role of PDE5
Cyclic Nucleotide Phosphodiesterases in Health and Disease provides an integrated volume covering PDE biology from genes to organisms. It examines phosphodiesterases as pharmacological targets as well as the development of specific PDE inhibitors as therapeutic agents. With contributions from pioneers in the field, individual chapters describe one of the 11 known mammalian PDE families including the molecular characteristics, structure, function, and traits unique to each.
Cyclic Nucleotide Phosphodiesterases in Health and Disease provides an integrated volume covering PDE biology from genes to organisms. It examines phosphodiesterases as pharmacological targets as well as the development of specific PDE inhibitors as therapeutic agents. With contributions from pioneers in the field, individual chapters describe one of the 11 known mammalian PDE families including the molecular characteristics, structure, function, and traits unique to each.
| Original language | English |
|---|---|
| Title of host publication | Cyclic Nucleotide Phosphodiesterases in Health and Diseases |
| Editors | J Beavo, S Francis, MD Houslay |
| Place of Publication | Boca Raton |
| Pages | 501-518 |
| Number of pages | 18 |
| DOIs | |
| Publication status | Published - 2006 |
Keywords
- pulmonary hypertension
- PDE5
- cyclic nucleotide phosphodiesterases